Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India

Posted On: 2020-12-01 05:48:12 (Time Zone: Arizona, USA)


Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), and Russian Direct Investment Fund (RDIF) announced today that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli, India.This will be a multicenter and randomized controlled study, which will include safety and immunogenicity study.

The clinical trials are being conducted by JSS Medical Research as the clinical research partner. Further, Dr. Reddy's has partnered with the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT) for advisory support and to use BIRAC's clinical trial centres for the vaccine.

Recently, RDIF announced the second interim analysis of clinical trial data, which showed 91.4% efficacy for the vaccine on day 28 after the first dose; vaccine efficacy over 95% 42 days after the first dose. Currently, 40,000 volunteers are taking part in Phase III of Sputnik V clinical trials, out of which over 22,000 have been vaccinated with the first dose of the vaccine and more than 19,000 - with both the first and second doses of the vaccine.

G V Prasad, Co-chairman and Managing Director, Dr. Reddy's Laboratories said, "This is another significant step as we continue to collaborate with multiple entities along with the government bodies to fast-track the process for launching the vaccine in India. We are working towards making the vaccine available with a combination of import and indigenous production model."

In September 2020, Dr. Reddy's and RDIF entered into a partnership to conduct clinical trials of the Sputnik V vaccine and the rights for distribution of the first 100 million doses in India.

On August 11, 2020, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the World's first registered vaccine against COVID-19 based on the human adenoviral vector platform.

Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.4833.5 as compared to the previous close of Rs. 4829.6. The total number of shares traded during the day was 31335 in over 4429 trades.

The stock hit an intraday high of Rs. 4868 and intraday low of 4805.9. The net turnover during the day was Rs. 151535368.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Raksha Mantri unveils India's First Indigenously Designed & Developed Driverless Metro Car

Dr. Reddy's receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India

L&T Finance Holdings Ltd posts consolidated PAT of Rs. 290.66 crore in Q3FY21

Shoppers Stop Ltd Q3FY21 consolidated loss at Rs. 25.11 crores

Plastiblends India Ltd reports net profit of Rs. 11.37 crore in Q3FY21

SORIL Infra Resources Ltd Q3FY21 consolidated PAT at Rs. 4.98 crore

Mastek's Group CEO Mr. John Owen quits

CFO Tech Outlook Recognizes Emagia As 'The Top 10 Account Receivable Solution Providers 2020'

MPCB issues closure notice to Bajaj Healthcare Limited's plant

Syncom Formulations India Ltd awarded by IPF Industrial Excellence Awards, 2021

Captain Polyplast Ltd announces capacity augmentation at Kurnool plant

ITC Limited conferred the ICSI National Award for Excellence in Corporate Governance

Hitachi Cooling and Heating launches country's first of its kind premium and luxurious air conditioning system 'SET FREE mini' for Indian market

Bhakti Gems and Jewellery Ltd Q3FY21 PAT soars to Rs. 2.07 crore

Fiat Chrysler Automobiles partners with Wipro to establish its first Global Digital Hub in India

PVR announces results for the Quarter Ended December 31, 2020

Route Mobile Ltd board to announce third quarter results on Jan 28, 2021

Maruti Suzuki India Ltd board to approve Q3FY21 results on Jan 28, 2021

Shree Cement Ltd board to consider 3rd quarter results on Jan 30, 2021

OnMobile Global Ltd board to announce Q3FY21 results on Feb 1, 2021

Page Industries Ltd board approve 2nd interim dividend, Q3 results on Feb 10, 2021

Polycab India Ltd board to announce third quarter results on Jan 23, 2021

Kotak Mahindra Bank Limited board to consider Q3FY21, 9MFY21 results on Jan 25, 2021

Hindustan Organic Chemicals Limited board to approve 3rd quarter results on Jan 27, 2021

Sukhjit Starch & Chemicals Ltd board to announce third quarter results on Jan 29, 2021

Canara Bank board to approve quarterly results on Jan 27, 2021

TeamLease Services Limited board to consider Q3FY21 results on Jan 28, 2021

Dhunseri Tea & Industries Ltd completes sale of Khetojan Tea Estate

GAIL India Ltd board approves interim dividend of Rs. 2.50 for FY21

Indian Oil Corporation Ltd board to announce Q3 results on Jan 29, 2021

V-Guard acquires non-controlling stake in a battery startup - Gegadyne Energy Labs Private Limited

Hathway Cable & Datacom Ltd Q3FY21 consolidated PAT at Rs. 62.56 crores

PVR Ltd posts consolidated loss of Rs. 49.10 crore in Q3FY21

Adtiya Birla Money Ltd posts Rs. 4.20 crore PAT in Q3FY21

GAIL India Ltd board approves buyback at Rs. 150

Onward Technologies Ltd Q3 consolidated net profit at Rs. 2.35 crore

SBI Cards and Payment Services Ltd board to announce Q3FY21 results on Jan 21, 2021

Vaibhav Global Ltd board to approve quarterly results, interim dividend on Jan 29, 2021

Sonata Software Ltd board to consider third 3rd quarter results on Feb 4, 2021

Goa Carbon Ltd board to announce Q3 results on Jan 28, 2021

Kopran Ltd board to approve third quarter results on Jan 22, 2021

Maruti Suzuki Smart Finance rolls out one-stop online finance facility for Maruti Suzuki ARENA customers

Symphony Ltd board to announce Q3FY21 results on Jan 22, 2021

UCO Bank board to consider 3rd quarter results on Jan 25, 2021

NELCO LTD board to announce Q3 results on Jan 28, 2021

Smart, safe and sustainable electrification delivers clean water supply in Surat

Mangalam Organics Limited board to approve third quarter results on Jan 22, 2021

Birla Precision Technologies Ltd board to consider allotment of 84,31,703 Equity Shares

Andhra Paper Ltd board to approve quarterly results on Jan 28, 2021

Tata Power Company Ltd board to announce Q3FY21 results on Feb 4, 2021



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020